Company profile ATHA
After 39 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 52 days it will total up to 33.0. Athira Pharma expected interest is significantly lower compared to same quarter last year (-52.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 45 inf% QoQ | 9 -80.0% QoQ | 21 133.3% QoQ |
| 2020 | 31 inf% YoY 47.6% QoQ | 68 51.1% YoY 119.4% QoQ | 182 1922.2% YoY 167.6% QoQ | 214 919.0% YoY 17.6% QoQ |
| 2021 | 148 377.4% YoY -30.8% QoQ | 322 373.5% YoY 117.6% QoQ | 243 33.5% YoY -24.5% QoQ | 129 -39.7% YoY -46.9% QoQ |
| 2022 | 98 -33.8% YoY -24.0% QoQ | 121 -62.4% YoY 23.5% QoQ | 71 -70.8% YoY -41.3% QoQ | 54 -58.1% YoY -23.9% QoQ |
| 2023 | 69 -29.6% YoY 27.8% QoQ | 133 9.9% YoY 92.8% QoQ | 109 53.5% YoY -18.0% QoQ | 49 -9.3% YoY -55.0% QoQ |
| 2024 | 14 -79.7% YoY -71.4% QoQ | - | - | - |
The average 5 years interest of Athira Pharma was 8.16 per week. The last year interest of Athira Pharma compared to the last 5 years has changed by -16.54%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 372.92%.
There is not enough data for ATH-1017 Fosgonimeton to provide analysis
There is not enough data for ATH-1017 Fosgonimeton to provide correlation calculation
There is not enough data for ATH-1017 Fosgonimeton to provide analysis
After 34 days of this quarter the interest is at 159.0. Based on that we can calculate that during remaining 58 days it will total up to 430.0. Alzheimer's disease treatment expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 177 |
| 2019 | 176 -0.6% QoQ | 151 -14.2% QoQ | 237 57.0% QoQ | 286 61.6% YoY 20.7% QoQ |
| 2020 | 277 57.4% YoY -3.1% QoQ | 184 21.9% YoY -33.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 159 inf% YoY inf% QoQ |
The average 5 years interest of Alzheimer's disease treatment was 6.31 per week. The last year interest of Alzheimer's disease treatment compared to the last 5 years has changed by -51.51%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -80.88%.
After 34 days of this quarter the interest is at 192.0. Based on that we can calculate that during remaining 58 days it will total up to 520.0. Parkinson's disease treatment expected interest is significantly higher compared to previous quarter (+100.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 266 |
| 2019 | 500 88.0% QoQ | 428 -14.4% QoQ | 362 -15.4% QoQ | 413 55.3% YoY 14.1% QoQ |
| 2020 | 404 -19.2% YoY -2.2% QoQ | 235 -45.1% YoY -41.8% QoQ | 217 -40.1% YoY -7.7% QoQ | 347 -16.0% YoY 59.9% QoQ |
| 2021 | 250 -38.1% YoY -28.0% QoQ | 161 -31.5% YoY -35.6% QoQ | 216 -0.5% YoY 34.2% QoQ | 271 -21.9% YoY 25.5% QoQ |
| 2022 | 357 42.8% YoY 31.7% QoQ | 324 101.2% YoY -9.2% QoQ | 296 37.0% YoY -8.6% QoQ | 461 70.1% YoY 55.7% QoQ |
| 2023 | 480 34.5% YoY 4.1% QoQ | 394 21.6% YoY -17.9% QoQ | 260 -12.2% YoY -34.0% QoQ | 192 -58.4% YoY -26.2% QoQ |
The average 5 years interest of Parkinson's disease treatment was 26.18 per week. The last year interest of Parkinson's disease treatment compared to the last 5 years has changed by 12.91%. The interest for Parkinson's disease treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by -13.54%.
After 34 days of this quarter the interest is at 170.0. Based on that we can calculate that during remaining 58 days it will total up to 460.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 222 |
| 2019 | 475 114.0% QoQ | 450 -5.3% QoQ | 363 -19.3% QoQ | 303 36.5% YoY -16.5% QoQ |
| 2020 | 290 -38.9% YoY -4.3% QoQ | 350 -22.2% YoY 20.7% QoQ | 424 16.8% YoY 21.1% QoQ | 365 20.5% YoY -13.9% QoQ |
| 2021 | 370 27.6% YoY 1.4% QoQ | 545 55.7% YoY 47.3% QoQ | 413 -2.6% YoY -24.2% QoQ | 326 -10.7% YoY -21.1% QoQ |
| 2022 | 389 5.1% YoY 19.3% QoQ | 428 -21.5% YoY 10.0% QoQ | 502 21.5% YoY 17.3% QoQ | 403 23.6% YoY -19.7% QoQ |
| 2023 | 425 9.3% YoY 5.5% QoQ | 523 22.2% YoY 23.1% QoQ | 425 -15.3% YoY -18.7% QoQ | 170 -57.8% YoY -60.0% QoQ |
The average 5 years interest of Neuropathic pain treatment was 31.27 per week. The last year interest of Neuropathic pain treatment compared to the last 5 years has changed by 11.26%. The interest for Neuropathic pain treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 11.54%.
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 92 inf% YoY inf% QoQ | 25 inf% YoY -72.8% QoQ |
| 2021 | 215 inf% YoY 760.0% QoQ | 197 inf% YoY -8.4% QoQ | 229 148.9% YoY 16.2% QoQ | 136 444.0% YoY -40.6% QoQ |
| 2022 | 90 -58.1% YoY -33.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Neurodegenerative disease treatment was 3.77 per week. The last year interest of Neurodegenerative disease treatment compared to the last 5 years has changed by -100.0%. This is something to be checked. This didn't exist 5 years ago.
After 39 days of this quarter the interest is at 144.0. Based on that we can calculate that during remaining 52 days it will total up to 336.0. Amyotrophic Lateral Sclerosis treatment expected interest is significantly higher compared to previous quarter (+261.3%) and same quarter last year (+156.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 55 | 98 78.2% QoQ | 120 22.4% QoQ | 131 9.2% QoQ |
| 2020 | 111 101.8% YoY -15.3% QoQ | 17 -82.7% YoY -84.7% QoQ | 55 -54.2% YoY 223.5% QoQ | 88 -32.8% YoY 60.0% QoQ |
| 2021 | 70 -36.9% YoY -20.5% QoQ | 31 82.4% YoY -55.7% QoQ | 111 101.8% YoY 258.1% QoQ | 116 31.8% YoY 4.5% QoQ |
| 2022 | 140 100.0% YoY 20.7% QoQ | 88 183.9% YoY -37.1% QoQ | 95 -14.4% YoY 8.0% QoQ | 62 -46.6% YoY -34.7% QoQ |
| 2023 | 131 -6.4% YoY 111.3% QoQ | 131 48.9% YoY 0.0% QoQ | 121 27.4% YoY -7.6% QoQ | 93 50.0% YoY -23.1% QoQ |
| 2024 | 144 9.9% YoY 54.8% QoQ | - | - | - |
The average 5 years interest of Amyotrophic Lateral Sclerosis treatment was 7.69 per week. The last year interest of Amyotrophic Lateral Sclerosis treatment compared to the last 5 years has changed by 43.82%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 26.11%.
There is not enough data for Athira Pharma clinical trials to provide analysis
There is not enough data for Athira Pharma clinical trials to provide correlation calculation
There is not enough data for Athira Pharma clinical trials to provide analysis
There is not enough data for Athira Pharma stock price to provide analysis
There is not enough data for Athira Pharma stock price to provide correlation calculation
There is not enough data for Athira Pharma stock price to provide analysis
After 39 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 52 days it will total up to 58.0. Athira Pharma news expected interest is significantly lower compared to same quarter last year (-44.2%) but higher than previous quarter (+81.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 96 | 113 17.7% QoQ | 59 -47.8% QoQ | 67 13.6% QoQ |
| 2020 | 112 16.7% YoY 67.2% QoQ | 64 -43.4% YoY -42.9% QoQ | 216 266.1% YoY 237.5% QoQ | 243 262.7% YoY 12.5% QoQ |
| 2021 | 151 34.8% YoY -37.9% QoQ | 100 56.2% YoY -33.8% QoQ | 107 -50.5% YoY 7.0% QoQ | 77 -68.3% YoY -28.0% QoQ |
| 2022 | 22 -85.4% YoY -71.4% QoQ | 34 -66.0% YoY 54.5% QoQ | 66 -38.3% YoY 94.1% QoQ | 55 -28.6% YoY -16.7% QoQ |
| 2023 | 104 372.7% YoY 89.1% QoQ | 120 252.9% YoY 15.4% QoQ | 159 140.9% YoY 32.5% QoQ | 32 -41.8% YoY -79.9% QoQ |
| 2024 | 25 -76.0% YoY -21.9% QoQ | - | - | - |
The average 5 years interest of Athira Pharma news was 7.75 per week. The last year interest of Athira Pharma news compared to the last 5 years has changed by 2.45%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 23.29%.